Tonix Pharmaceuticals Holding Corp. logo

Tonix Pharmaceuticals Holding Corp.

TNXP | NASDAQ
Chart Builder DCF Calculator
$10.89
+$0.17 (+1.59%)
Sep 22, 2026, 11:50 AM ET · Market open

Market Data

Market Cap
$170.89M
Enterprise Value
$-4.07M
Beta
1.75
Average Volume
506.1K
Shares Outstanding (Diluted)
16.64M
Shares Change YoY
127.03%
Institutional Ownership
35.52%
Exchange
NASDAQ
ISIN
US8902608392

Price Performance

Price Change 1M
-16.8%
Price Change 3M
-10.4%
Price Change 6M
-28.5%
Price Change YTD
-35.2%
Price Change 1Y
-60.0%
Price Change 3Y
-99.6%
Price Change 5Y
-100.0%
1M CAGR (ann.)
-10.9%
1Y CAGR (ann.)
-62.2%
5Y CAGR (ann.)
-87.9%
All-Time CAGR
-71.6%

Valuation

PE Ratio
-0.81
Forward PE
N/A
PEG Ratio
-0.07
Forward PEG
0.03
PS Ratio
5.87
Forward PS
1.50
PB Ratio
0.77
P/FCF Ratio
-1.08
P/Adj. FCF Ratio
-1.03
P/OCF Ratio
-1.15
EV/Sales
-0.14
EV/EBIT
0.03
EV/EBITDA
0.03
EV/FCF
0.03
Earnings Yield
-123.5%
FCF Yield
-92.5%
Adj. FCF Yield
-97.1%

Financial Health

Net Cash
$176.23M
Total Debt
$1.27M
Cash & Short-Term Investments
$176.23M
Total Assets
$254.09M
Current Ratio
6.61
Quick Ratio
6.61
Debt / Equity Ratio
0.01
Debt / EBITDA
-0.01
Debt / FCF
-0.01
OCF / Debt
-120.28
Interest Coverage
0.00
Altman Z-Score
-3.07
Piotroski F-Score
3

Margins & Profitability

Gross Profit Margin
80.3%
Operating Profit Margin
-568.4%
EBITDA Margin
-541.4%
Net Profit Margin
-548.6%
FCF Margin
-543.3%
Adj. FCF Margin
-570.2%
SBC / Revenue
20.7%
SBC Impact (per share)
-5.0%

Returns

Return on Assets
-62.8%
Return on Equity
-69.0%
Return on Invested Capital
-74.0%
Return on Capital Employed
-74.1%
Return on Tangible Assets
-62.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
48.6%
Revenue CAGR 5Y
66.2%
Revenue CAGR 10Y
46.4%
EPS CAGR 3Y
149.3%
EPS CAGR 5Y
78.9%
EPS CAGR 10Y
48.2%
FCF CAGR 3Y
-41.1%
FCF CAGR 5Y
4.2%
FCF CAGR 10Y
-16.9%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
7
EPS Growth Next 3Y
26.9%
Revenue Growth Next 3Y
108.6%
Earnings Date
Nov 8, 2026
EPS Estimate (next Q)
-$2.45
EPS Growth Est (next Q)
-31.8%
Revenue Est (next Q)
$15.87M
Revenue Growth Est (next Q)
382.4%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$27
Price Target Upside
151.9%

Cash Flow

Operating Cash Flow
$-152.99M
Free Cash Flow
$-158.11M
Adj. Free Cash Flow
$-165.94M
FCF Per Share
-$9.61
OCF Per Share
-$9.30
OCF/S Ratio
-531.6%

Income Statement

Revenue
$29.1M
Gross Profit
$23.35M
Operating Income
$-165.43M
EBITDA
$-157.56M
Net Income
$-159.67M
EPS (Diluted)
-$13.24
Revenue / Employee
$204.94K
Profit / Employee
$-1.12M
Employees
142

© 2026 bestshares.com. All rights reserved.